On December 30, 2024, the Massachusetts Legislature passed House No. 4653, “An Act Enhancing the Health Care Market Review Process.” This bill includes sweeping changes focused on increased regulatory oversight and healthcare...more
1/2/2025
/ Determination of Need (DoN) ,
Equity Investors ,
Health Care Providers ,
Healthcare ,
Investors ,
Pharmaceutical Industry ,
Pharmacy Benefit Manager (PBM) ,
Regulatory Oversight ,
REIT ,
Reporting Requirements ,
State Health Plans
During the October 11, 2023, Massachusetts Public Health Council Meeting, staff representing the Department of Public Health’s Drug Control Program introduced proposed revisions to 105 CMR 700.000: Implementation of M.G.L....more